The role of artificial intelligence in pharmacovigilance for rare diseases
Year: 2025
Type: article
Source: Expert Opinion on Drug Safety
Authors: Ashish Jain, Zahabia Adenwala
Institutions: Curis (United States), Seres Therapeutics (United States)
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4408078943
